Citing significant progress on a cure for diabetes, Novo Nordisk beefs up its stem cell pipeline with new collaborations
A growing group of biotech startups looking to advance a lineup of potential stem cell cures for Type 1 diabetes can look to a big …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
